Colleen Grady: Why Normal Hemoglobin Does Not Exclude Iron Deficiency
Colleen Grady, Operations Director and Nurse Practitioner at Rocky Mountain Regenerative Medicine, shared a post on LinkedIn about an article by F Verdon et al. published in BMJ, adding:
“Iron deficiency is the most common nutritional deficiency in the world.
In women of reproductive age and perimenopausal women, it is also one of the most consistently missed in clinical practice.
Not because the testing is unavailable.
Because the wrong test is being used.
The standard test for iron status in most clinical settings is hemoglobin. If hemoglobin is within normal range, iron status is assumed to be adequate. The patient is told their blood count is fine.
But hemoglobin does not become affected by iron deficiency until the deficiency is severe. In the earlier stages, what is called iron deficiency without anemia or latent iron deficiency, hemoglobin is perfectly normal while ferritin, the storage form of iron, is critically depleted.
And ferritin depletion in the absence of anemia produces a specific and recognizable symptom cluster:
- Persistent fatigue that is disproportionate to sleep and activity levels
- Cognitive impairment, particularly working memory and processing speed
- Hair loss and changes in hair texture
- Restless legs syndrome and disrupted sleep
- Reduced exercise tolerance and prolonged recovery
- Low mood and increased anxiety
A 2003 randomized controlled trial published in the Lancet, one of the most cited studies in this area, enrolled women with unexplained fatigue and ferritin below 50 micrograms per liter but normal hemoglobin.
Women treated with IV iron showed statistically significant improvements in fatigue scores, cognitive function and quality of life compared to placebo.
Their hemoglobin had been normal throughout.
The standard test would have found nothing to treat.”
Title: Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial
Authors: F Verdon, B Burnand, C-L Fallab Stubi, C Bonard, M Graff, A Michaud, T Bischoff, M de Vevey, J-P Studer, L Herzig, C Chapuis, J Tissot, A Pécoud, B Favrat

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery